Application of drug-receptor theories to angiotensin.
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D001285:Atropine / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D010455:Peptides / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology; D013270:Stomach / Q000187:drug effects; D013329:Structure-Activity Relationship
D010455:Peptides; D011453:Prostaglandins; D011956:Receptors, Cell Surface; D011955:Receptors, Drug; D000804:Angiotensin II; D012701:Serotonin; D009020:Morphine; D001285:Atropine; D006632:Histamine; D004155:Diphenhydramine; D003042:Cocaine; D000109:Acetylcholine; D007213:Indomethacin; D008784:Methysergide; D010646:Phentolamine